E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 7/8/2013 in the Prospect News PIPE Daily.

Anavex announces $12.56 million units sale, stock purchase agreement

Offering sells units with five-year warrants, shares to Lincoln Park

By Devika Patel

Knoxville, Tenn., July 8 - Anavex Life Sciences Corp. settled a private placement of units for $2.56 million and negotiated a $10 million common stock purchase agreement with Lincoln Park Capital Fund, LLC on July 5, according to an 8-K filed Monday with the Securities and Exchange Commission. William Blair & Co., LLC is the agent for the units sale.

The company sold 6,406,043 units of one common share and a warrant at $0.40 per unit.

The warrants are each exercisable at $0.75 for five years. The strike price represents a 17.19% premium to the June 20 closing share price of $0.64.

In the three-year stock purchase agreement, Lincoln Park has already bought 250,000 shares for $100,000. The investor received 341,858 shares as a commitment fee.

Proceeds will be used to help advance human clinical trials of Anavex 2-73 and for general corporate purposes

Anavex is a pharmaceutical company based in Hoboken, N.J.

Issuer:Anavex Life Sciences Corp.
Issue:Units of one common share and a warrant, stock purchase agreement
Amount:$12,562,417
Pricing date:July 5
Stock symbol:OTCBB: AVXL
Stock price:$0.64 at close July 3
Market capitalization:$16.81 million
Units
Amount:$2,562,417
Units:6,406,043
Price:$0.40
Warrants:One warrant per unit
Warrant expiration:Five years
Warrant strike price:$0.75
Agent:William Blair & Co., LLC
Settlement date:July 5
Stock purchase agreement
Amount:$10 million
Tenor:Three years
Pricing date:July 5
Settlement date:July 5 (for $100,000)
Investor:Lincoln Park Capital Fund, LLC
Fees:341,858 shares

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.